APVO Aptevo Therapeutics Inc.
1.840USD+2.51%Mkt Cap: 3.33M $P/E: 0.031d ago
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap3.33M USD
Enterprise Value-2.35M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-25.97M USD
Revenue/Share—
Last Price1.840 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees33
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.03
P/E (Forward)-0.17
PEG—
EV/EBITDA0.09
EV/Revenue—
P/S—
P/B0.42
EPS (TTM)66.96
EPS (Forward)-10.40
52W Range
1.3701% of range35.64
52W High35.64 USD
52W Low1.370 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-149.40%
ROA-95.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.59M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-467.30%
Net Debt-5.59M USD
Net Debt/EBITDA0.21
Balance Sheet
Debt/Equity0.27
Current Ratio2.08
Quick Ratio1.89
Book Value/Sh4.26 USD
Cash/Share5.44 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 27, 2020
Splits
Last Split1:18
Split DateDec 30, 2025
Analyst Consensus
Rating—
Target (Mean)25.50 USD
Upside (mean)+1285.9%
Target Range21.00 USD – 30.00 USD
21.00+1285.9% to mean30.00
# Analysts2
Ownership
Shares Out.1.81M
Float1.70M
Insiders4.15%
Institutions2.88%
Short Interest
Short Ratio1.0d
Short % Float10.99%
Short % Out.10.38%
Shares Short187.94K
Short (prev mo.)81.75K
Technical
SMA 502.647 (-30.5%)
SMA 2005.372 (-65.7%)
Beta1.68
S&P 52W Chg16.45%
Avg Vol (30d)141.35K
Avg Vol (10d)30.28K
Technical Indicators
RSI (14)35.4
MACD-0.2581
MACD Signal-0.3325
MACD Hist.+0.0743
BB Upper1.925 USD
BB Middle1.827 USD
BB Lower1.729 USD
BB Width10.71%
ATR (14)0.1498 USD
Vol Ratio (20d)0.22x